ויקטרליס
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BOCEPREVIR 200 MG
Available from:
MERCK SHARP & DOHME ISRAEL LTD
ATC code:
J05AE12
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
MERCK SHARP & DOHME CORP., USA
Therapeutic group:
BOCEPREVIR
Therapeutic indications:
VICTRELIS (boceprevir) is indicated for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.
Authorization date:
2012-02-01
